Fundz

Capra Biosciences Raises $1.8M In Pre-Seed Round For Renewable Chemical Innovations

PRIVATEJun 06, 2022

Amount Raised

$1.8 Million

Round Type

Pre-Seed

ManassasBiotechnology

Description

Capra Biosciences (Capra) today officially announced it has raised $1.8 million in an oversubscribed pre-seed funding round to advance their continuous-flow bioreactor technology, which changes the economics of making sustainable petrochemical replacements using biology. Capra will use the funding to build their production-scale reactor and extend its capabilities to include the production of lubricants.

Quick answer

Capra Biosciences raised $1.8 Million in a Pre-Seed round, dated June 6, 2022. Capra Biosciences is based in Manassas, Virginia, United States.

How much did Capra Biosciences raise?
Capra Biosciences raised $1.8 Million in a Pre-Seed round on June 6, 2022.
What does Capra Biosciences do?
Capra Biosciences is developing a new technology that will make the manufacturing of chemicals using biology cost-competitive with petroleum-based products.
Where is Capra Biosciences based and how big is it?
Capra Biosciences is based in Manassas, Virginia, United States.
Who are the decision-makers at Capra Biosciences?
Fundz holds 1 contact at Capra Biosciences, including the Executive Officer, Director, Promoter. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Capra Biosciences that raised within 45 days of this round, from Fundz verified event records.

  • Empatica raised $26M on July 21, 2022.
  • 22nd Century raised $35M on July 21, 2022.
  • Exact Imaging raised an undisclosed amount (Funding Round) on July 21, 2022.
  • Camp4 Therapeutics Corp raised $100M (Series B) on July 20, 2022.
  • Sequana Medical raised $11M (Debt Financing) on July 20, 2022.
  • KaloCyte raised an undisclosed amount on July 20, 2022.

Who to call at Capra Biosciences, and when

A new round usually means Capra Biosciences is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Capra Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Capra Biosciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Capra Biosciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Capra Biosciences

Location

11100 ENDEAVOR CT UNIT 149

Manassas, Virginia, United States

About

Capra Biosciences is developing a new technology that will make the manufacturing of chemicals using biology cost-competitive with petroleum-based products. Significant advances in synthetic biology have been made over the past 20 years, enabling a multitude of products with lower environmental impact and potentially better performance than their petrochemical counterparts. However, cost-competitive large-scale manufacturing of these products remains a significant bottleneck to their adaptation. Our technology tackles this bottleneck through an innovative bioreactor design that promises to significantly reduce end-to-end manufacturing costs.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Capra Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsAndrew M., Executive Officer, Director, Promoter hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Capra Biosciences's next move

See what Strategic adds

Capra Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.